Alaunos Therapeutics, Inc.·4

Nov 26, 9:26 PM ET

Postma Robert W 4

4 · Alaunos Therapeutics, Inc. · Filed Nov 26, 2025

Insider Transaction Report

Form 4
Period: 2025-11-21
Transactions
  • Award

    Common Stock

    2025-11-21$3.16/sh+5,142$16,24938,250 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    13
  • Common Stock

    (indirect: By WaterMill Asset Management Corp.)
    33,333
Footnotes (2)
  • [F1]Represents shares of common stock issued in lieu of board fees.
  • [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4